BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6860419)

  • 1. Critical study of staging in multiple myeloma.
    Pennec Y; Mottier D; Youinou P; Asselain B; Chavance M; Le Goff P; Le Prise PY; Miossec P; Le Menn G
    Scand J Haematol; 1983 Feb; 30(2):183-90. PubMed ID: 6860419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of criteria in staging in multiple myeloma.
    Pennec Y; Mottier D; Youinou P; Asselain B; Miossec P; Le Goff P; Le Prise PY; Le Menn G
    Haematologia (Budap); 1982; 15(2):221-6. PubMed ID: 7160667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical staging in multiple myeloma.
    Woodruff RK; Wadsworth J; Malpas JS; Tobias JS
    Br J Haematol; 1979 Jun; 42(2):199-205. PubMed ID: 465365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic assessment of the Durie and Salmon staging system in patients with multiple myeloma.
    Spasov E; Goranova V
    Folia Med (Plovdiv); 1998; 40(3B Suppl 3):121-3. PubMed ID: 10206011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
    Pertuiset E; Chevret S; Lioté F; Delauche MC; Bardin T; Dryll A; Kuntz D
    Ann Med Interne (Paris); 1992; 143(8):519-24. PubMed ID: 1303595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of
    Deng S; Zhang B; Zhou Y; Xu X; Li J; Sang S; Zhang W
    Contrast Media Mol Imaging; 2018; 2018():4198673. PubMed ID: 30154686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and survival of Chilean patients with multiple myeloma].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2007 Sep; 135(9):1111-7. PubMed ID: 18064364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
    Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International staging system for multiple myeloma.
    Greipp PR; San Miguel J; Durie BG; Crowley JJ; Barlogie B; Bladé J; Boccadoro M; Child JA; Avet-Loiseau H; Kyle RA; Lahuerta JJ; Ludwig H; Morgan G; Powles R; Shimizu K; Shustik C; Sonneveld P; Tosi P; Turesson I; Westin J
    J Clin Oncol; 2005 May; 23(15):3412-20. PubMed ID: 15809451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical staging and therapeutic results in multiple myeloma.
    Santoro A; Schieppati G; Franchi F; Valagussa P; Monfardini S
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1353-9. PubMed ID: 6685627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in IgG and micromolecular multiple myeloma. Retrospective analysis of 50 consecutive cases].
    Pasqualetti P; Casale R; Colantonio D; Festuccia V; Di Lauro G; Natali G
    Minerva Med; 1987 May; 78(9):603-8. PubMed ID: 3587727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The percentage of bone marrow plasmacytes and prognosis in multiple myeloma].
    Paule B; Quillard J; Bennet P; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):969-72. PubMed ID: 3238308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two staging systems for myeloma.
    Vercelli D; Cozzolino F; Di Guglielmo R
    Nouv Rev Fr Hematol (1978); 1981; 23(2):107-10. PubMed ID: 7290984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening of prognostic factors and comparing of staging systems of multiple myeloma].
    Li J; Wu XB; Zhou Y; Wang X; Chen JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):926-9. PubMed ID: 22931656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging and survival in multiple myeloma.
    Wahlin A
    Scand J Haematol; 1984 Jul; 33(1):22-6. PubMed ID: 6463584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
    Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic variables and clinical staging in multiple myeloma.
    Cavo M; Galieni P; Zuffa E; Baccarani M; Gobbi M; Tura S
    Blood; 1989 Oct; 74(5):1774-80. PubMed ID: 2790201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.